Live Quote · NASDAQBDSXHealthcare· Medical - Diagnostics & Research

Biodesix, Inc.

$21.99 10.24%($-2.51)
TickerSpark Score
70/100
Solid
47
Valuation
40
Profitability
95
Growth
68
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDSX research report →

52-Week Range85% of range
Low
$5.26
Current
$21.99
High
$24.91
Company Overviewwww.biodesix.com

About the company

Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lung Nodule Risk Assessment (which includes Nodify XL2 and Nodify CDT).

CEO
Scott Hutton
IPO
2020
Employees
273
HQ
Boulder, CO, US

Price Chart

+299.82% · this period
$24.50$14.96$5.43Jul 02Dec 31Jul 02
Valuation
Market Cap
$179.00M
P/E
-6.64
P/S
1.86
P/B
23.25
EV/EBITDA
-12.27
Div Yield
0.00%
Profitability
Gross Margin
82.08%
Op Margin
-25.91%
Net Margin
-33.26%
ROE
-2101.40%
ROIC
-30.51%
Growth & Income
Revenue
$88.50M · 24.08%
Net Income
$-35,265,000 · 17.86%
EPS
$-4.67 · 29.24%
Op Income
$-27,766,000
FCF YoY
54.37%
Performance & Tape
52W High
$24.91
52W Low
$5.26
50D MA
$15.49
200D MA
$11.37
Beta
0.52
Avg Volume
74.38K

Get TickerSpark's AI analysis on BDSX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26PATIENCE JOHNother1,361
Jun 30, 26PATIENCE JOHNother1,361
Mar 31, 26PATIENCE JOHNother1,361
Mar 31, 26PATIENCE JOHNother1,361
Feb 20, 26Pestano Gary Anthonyother1,528
Feb 23, 26Pestano Gary Anthonysell556
Feb 20, 26Pestano Gary Anthonyother1,528
Feb 20, 26O'Kane Kieranother1,469
Feb 23, 26O'Kane Kieransell535
Feb 20, 26O'Kane Kieranother1,469
Coverage · BDSX

Our BDSX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on BDSX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate BDSX report →
Internal Compare

Similar companies

Peers in the same neighborhood.